nuc
ntp
synthes
gilead
scienc
inc
chemic
ident
sampl
puriti
establish
use
nmr
hrm
hplc
analysi
supplementari
inform
radiolabel
analogu
specif
activ
mcimmol
obtain
moravek
biochem
brea
ca
prepar
similar
manner
describ
use
trimethylsilylcyanid
supplementari
inform
small
molecul
xray
crystallograph
coordin
structur
factor
file
deposit
cambridg
structur
databas
http
wwwccdccamacuk
access
number
suppli
supplementari
inform
rsv
purchas
advanc
biotechnolog
inc
ebov
kikwit
makona
variant
sudan
viru
sudv
gulu
marburg
viru
marv
junin
viru
junv
romero
lassa
viru
lasv
josiah
middl
east
respiratori
syndrom
viru
mer
jordan
chikungunya
viru
chiv
af
venezuelan
equin
enceph
viru
veev
prepar
character
usamriid
ebov
contain
gfp
report
gene
ebovgfp
ebov
makona
liberia
marv
contain
gfp
report
gene
marvgfp
prepar
character
center
diseas
control
prevent
cdc
hela
vero
cell
line
purchas
american
type
cultur
collect
cell
line
authent
test
mycoplasma
part
routin
use
assay
cell
cultur
eagl
minimum
essenti
media
mem
supplement
fetal
bovin
serum
fb
unitsml
penicillin
streptomycin
cell
cultur
kaighn
media
supplement
fb
unitsml
penicillin
streptomycin
hela
vero
cell
cultur
mem
supplement
fb
lglutamin
mm
hepe
nonessenti
amino
acid
penicillinstreptomycin
cell
cultur
mem
supplement
fb
mm
sodium
pyruv
cell
cultur
dulbecco
modifi
eagl
medium
dmem
supplement
fb
unitsml
penicillin
streptomycin
mm
nonessenti
amino
acid
cell
line
obtain
nih
aid
research
refer
reagent
program
cultur
medium
supplement
fb
unitsml
penicillin
streptomycin
mm
lglutamin
cell
line
obtain
dr
charl
rice
rockefel
univers
cultur
dmem
supplement
fb
unitsml
penicillin
streptomycin
nonessenti
amino
acid
primari
human
hepatocyt
purchas
invitrogen
cultur
william
medium
e
medium
contain
cell
mainten
supplement
donor
profil
limit
nonsmok
limit
alcohol
consumpt
upon
deliveri
cell
allow
recov
h
complet
medium
supplement
provid
vendor
human
peripher
blood
mononuclear
cell
pbmc
isol
human
buffi
coat
obtain
healthi
volunt
stanford
medic
school
blood
center
palo
alto
ca
maintain
supplement
fb
unitsml
penicillin
streptomycin
rhesu
fresh
whole
blood
obtain
valley
biosystem
sacramento
ca
pbmc
isol
whole
blood
ficollhypaqu
densiti
gradient
centrifug
briefli
blood
overlaid
ml
ge
healthcar
bioscienc
ab
piscataway
nj
centrifug
g
minut
top
layer
contain
platelet
plasma
remov
middl
layer
contain
pbmc
transfer
fresh
tube
dilut
tri
buffer
salin
ml
centrifug
g
minut
supernat
remov
cell
pellet
resuspend
ml
red
blood
cell
lysi
buffer
mm
ammonium
chlorid
mm
potassium
bicarbon
mm
edta
ph
gener
stimul
pbmc
freshli
isol
quiescent
pbmc
seed
tissu
cultur
flask
contain
fresh
medium
supplement
unitsml
recombin
human
phytohemagglutininp
densiti
cellsml
incub
h
human
macrophag
cultur
isol
pbmc
purifi
ficol
gradient
centrifug
ml
blood
healthi
human
volunt
pbmc
cultur
day
rpmi
cell
cultur
media
supplement
fb
ngml
granulocytemacrophag
colonystimul
factor
gmcsf
bme
induc
macrophag
differenti
cryopreserv
human
primari
renal
proxim
tubul
epitheli
cell
obtain
lifelin
cell
technolog
isol
tissu
human
kidney
cell
cultur
confluenc
renalif
complet
medium
flask
day
seed
assay
plate
immort
human
microvascular
endotheli
cell
hmvectert
obtain
dr
rong
shao
pioneer
valley
life
scienc
hmvectert
cell
cultur
endotheli
basal
media
supplement
fb
epitheli
growth
factor
mg
hydrocortison
gentamycinamphotericinb
rna
polii
purchas
part
nuclear
extract
vitro
transcript
system
kit
promega
recombin
human
polrmt
transcript
factor
mitochondri
transcript
factor
mttfa
tfam
purchas
enzymax
rsv
ribonucleoprotein
rnp
complex
prepar
accord
method
modifi
mason
et
intracellular
metabol
assess
differ
cell
type
hmvec
hela
primari
human
rhesu
pbmc
monocyt
monocyt
deriv
macrophag
follow
puls
continu
incub
comparison
intracellular
metabol
incub
nuc
complet
human
monocyt
deriv
macrophag
puls
incub
monocyt
deriv
macrophag
isol
rhesu
human
incub
h
compound
contain
media
follow
remov
wash
drugfre
media
incub
addit
h
media
contain
human
monocyt
deriv
macrophag
hela
hmvec
grown
confluenc
approxim
cellswel
respect
media
well
tissu
cultur
plate
monocyt
pbmc
incub
suspens
approxim
cellsml
ml
media
micro
centrifug
tube
adher
cell
hmvec
hela
monocyt
deriv
macrophag
media
remov
select
time
point
duplic
well
cell
wash
twice
ml
ice
cold
normal
salin
nonadher
cell
monocyt
pbmc
duplic
incub
centrifug
rpm
second
remov
media
cell
pellet
resuspend
cell
cultur
media
rpmi
fb
layer
top
oil
layer
nyosil
nye
lubric
fairhaven
microcentrifug
tube
sampl
centrifug
room
temperatur
rpm
second
media
layer
remov
oil
layer
wash
twice
water
oil
layer
care
remov
use
pasteur
pipet
attach
vacuum
volum
ml
methanol
contain
nm
analyt
intern
standard
sigmaaldrich
st
loui
mo
ad
isol
cell
sampl
store
overnight
facilit
extract
centrifug
g
minut
supernat
transfer
clean
tube
dri
mivac
duo
concentr
genevac
gardin
ny
dri
sampl
reconstitut
mobil
phase
contain
mm
ammonium
format
mm
dimethylhexylamin
dmh
water
analysi
liquid
chromatographi
coupl
tripl
quadrupol
mass
spectrometri
lcmsm
lcmsm
done
use
low
flow
ion
pair
chromatographi
similar
method
describ
briefli
analyt
separ
use
mm
luna
hst
column
phenomenex
torranc
ca
usa
connect
shimadzu
columbia
md
ternari
pump
system
ht
pal
autosampl
leap
technolog
carrboro
nc
multistag
linear
gradient
acetonitril
mobil
phase
contain
mm
ammonium
format
ph
mm
dimethylhexylamin
minut
flow
rate
use
separ
analyt
detect
perform
api
appli
biosystem
foster
citi
ca
msm
oper
posit
ion
multipl
reaction
monitor
mode
intracellular
metabolit
alamet
nuc
nmp
ndp
ntp
quantifi
use
point
standard
curv
rang
pmol
approxim
prepar
cell
extract
untreat
cell
level
adenosin
nucleotid
also
quantifi
assur
dephosphoryl
taken
place
sampl
collect
prepar
order
calcul
intracellular
concentr
metabolit
total
number
cell
per
sampl
count
use
countess
autom
cell
counter
invitrogen
carlsbad
ca
antivir
assay
conduct
biosafeti
contain
cdc
ebov
antivir
assay
conduct
primari
hmvectert
cell
cell
authent
test
mycoplasma
ten
concentr
compound
dilut
serial
dilut
increment
media
per
well
dilut
transfer
duplic
quadrupl
hmvectert
onto
assay
plate
contain
cell
monolay
plate
transfer
contain
appropri
dilut
viru
stock
ad
test
plate
contain
cell
serial
dilut
compound
plate
includ
four
well
infect
untreat
cell
four
well
uninfect
cell
serv
viru
inhibit
control
respect
infect
assay
plate
incub
day
day
hmvectert
tissu
cultur
incub
viru
replic
measur
direct
fluoresc
use
biotek
htsynergi
plate
reader
viru
yield
assay
cell
infect
wildtyp
ebov
h
pfu
per
cell
viru
inoculum
remov
replac
per
well
media
contain
appropri
dilut
compound
day
postinfect
supernat
collect
amount
viru
quantifi
endpoint
dilut
assay
endpoint
dilut
assay
conduct
prepar
serial
dilut
assay
media
ad
dilut
fresh
vero
cell
monolay
plate
determin
tissu
cultur
infecti
dose
caus
cytopath
effect
measur
level
viral
rna
infect
cell
total
rna
extract
use
total
rna
isol
kit
quantifi
use
quantit
revers
transcript
polymeras
chain
reaction
qrtpcr
assay
primer
probe
specif
ebov
nucleoprotein
gene
antivir
assay
conduct
usamriid
hela
cell
seed
cell
per
well
plate
ten
serial
dilut
compound
triplic
ad
directli
cell
cultur
use
hp
digit
dispens
hewlett
packard
palo
alto
ca
dilut
increment
start
h
prior
infect
dmso
concentr
well
normal
use
hp
digit
dispens
assay
plate
transfer
suit
infect
ebovkikwit
multipl
infect
pfu
per
cell
hela
cell
ebovmakona
multipl
infect
pfu
per
cell
cell
assay
plate
incub
tissu
cultur
incub
h
infect
termin
fix
sampl
formalin
solut
addit
h
prior
immunestain
describ
supplementari
tabl
antivir
assay
conduct
usamriid
primari
human
macrophag
cell
seed
plate
cell
per
well
eight
ten
serial
dilut
compound
triplic
ad
directli
cell
cultur
use
hp
digit
dispens
dilut
increment
h
prior
infect
concentr
dmso
normal
well
plate
transfer
suit
cell
infect
pfu
per
cell
ebov
media
incub
h
inoculum
remov
media
replac
fresh
media
contain
dilut
compound
h
postinfect
viru
replic
quantifi
immunostain
describ
supplementari
tabl
antivir
test
compound
serial
dilut
sourc
plate
nl
dilut
compound
transfer
cell
cultur
plate
use
echo
acoust
transfer
apparatu
cell
densiti
cellsml
infect
ad
rsv
titer
tissu
cultur
infecti
dose
ml
immedi
follow
viru
addit
viruscel
mixtur
ad
cell
cultur
plate
use
liquid
dispens
cultur
day
incub
cell
allow
equilibr
minut
rsvinduc
cytopath
effect
determin
ad
viabil
reagent
incub
cell
viabil
determin
measur
luminesc
use
envis
plate
reader
antivir
assay
conduct
plate
usamriid
use
highcont
imag
system
quantifi
viru
antigen
product
measur
viru
infect
viru
control
dmso
control
includ
determin
viru
infect
respect
primari
secondari
antibodi
dye
use
nuclear
cytoplasm
stain
list
supplementari
tabl
primari
antibodi
specif
particular
viral
protein
dilut
block
buffer
pb
bsa
ad
well
assay
plate
assay
plate
incub
minut
room
temperatur
primari
antibodi
remov
cell
wash
time
pb
secondari
detect
antibodi
antimous
rabbit
igg
conjug
thermo
fisher
scientif
waltham
cat
secondari
antibodi
dilut
block
buffer
ad
well
assay
plate
assay
plate
incub
minut
room
temperatur
nuclei
stain
use
biostatu
shepsh
leicestershir
uk
hoechst
thermofish
scientif
vero
cell
line
dye
dilut
pb
cytoplasm
ebov
assay
vero
mer
assay
cell
counterstain
deep
red
thermo
fisher
scientif
waltham
cell
imag
acquir
use
perkin
elmer
opera
confoc
plate
reader
perkin
elmer
waltham
use
air
object
collect
five
imag
per
well
virusspecif
antigen
quantifi
measur
fluoresc
emiss
nm
wavelength
stain
nuclei
quantifi
measur
fluoresc
emiss
nm
wavelength
acquir
imag
analyz
use
harmoni
acapella
pe
softwar
signal
use
gener
nuclei
mask
defin
nuclei
imag
quantif
cell
number
cellmask
deep
red
dye
use
demarc
vero
cell
border
cellnumb
quantit
viralantigen
signal
compartment
within
cell
mask
cell
exhibit
antigen
signal
higher
select
threshold
count
posit
viral
infect
ratio
viru
posit
cell
total
number
analyz
cell
use
determin
percent
infect
well
assay
plate
effect
compound
viral
infect
assess
percent
inhibit
infect
comparison
control
well
result
cell
number
percent
infect
normal
assay
plate
valu
antivir
assay
analysi
dose
respons
curv
perform
use
genedata
screener
softwar
appli
levenbergmarquardt
algorithm
lma
curv
fit
strategi
curvefit
process
includ
individu
data
point
exclus
prespecifi
default
softwar
set
quantifi
good
fit
fit
strategi
consid
accept
hela
cell
seed
cellswel
plate
compound
ad
assay
plate
assay
plate
transfer
suit
infect
pfu
per
cell
marv
result
cell
express
viru
antigen
period
viru
infect
quantifi
immunostain
use
antibodi
recogn
viral
glycoprotein
describ
supplementari
tabl
hela
cell
seed
cellswel
plate
compound
ad
assay
plate
assay
plate
transfer
suit
infect
pfu
sudv
per
cell
result
cell
express
viru
antigen
period
viru
infect
quantifi
immunostain
use
antibodi
recogn
viral
glycoprotein
describ
supplementari
tabl
hela
cell
seed
cellswel
plate
compound
ad
assay
plate
assay
plate
transfer
suit
infect
pfu
per
cell
junv
result
cell
express
viru
antigen
period
viru
infect
quantifi
immunostain
use
antibodi
recogn
viral
glycoprotein
describ
supplementari
tabl
hela
cell
seed
cellswel
plate
compound
ad
assay
plate
assay
plate
transfer
suit
infect
pfu
per
cell
lasv
result
cell
express
viru
antigen
period
viru
infect
quantifi
immunostain
use
antibodi
recogn
viral
glycoprotein
describ
supplementari
tabl
african
green
monkey
chlorocebu
sp
kidney
epitheli
cell
vero
seed
cell
per
well
plate
compound
ad
assay
plate
assay
plate
transfer
suit
infect
pfu
per
cell
mer
viru
result
cell
express
viru
antigen
period
viru
infect
quantifi
immunostain
use
antibodi
recogn
viral
glycoprotein
describ
supplementari
tabl
cell
seed
cell
per
well
plate
compound
ad
assay
plate
assay
plate
transfer
suit
infect
pfu
per
cell
chik
result
cell
express
viru
antigen
period
viru
infect
quantifi
immunostain
use
antibodi
recogn
viral
glycoprotein
describ
supplementari
tabl
hela
cell
seed
cell
per
well
plate
compound
ad
assay
plate
assay
plate
transfer
suit
infect
pfu
per
cell
veev
result
cell
express
viru
antigen
period
viru
infect
quantifi
immunostain
use
antibodi
recogn
viral
glycoprotein
describ
supplementari
tabl
cellswel
cellswel
cell
plate
plate
incub
appropri
medium
contain
serial
dilut
compound
rang
nm
nm
cellswel
cellswel
hepatocyt
cellswel
quiescent
pbmc
cellswel
stimul
pbmc
cellswel
rptec
cellswel
cell
plate
plate
incub
appropri
medium
contain
serial
dilut
compound
rang
nm
nm
cell
cultur
day
follow
incub
cell
allow
equilibr
cell
viabil
determin
ad
celltit
glo
viabil
reagent
mixtur
incub
minut
luminesc
signal
quantifi
use
envis
plate
reader
cell
line
authent
test
mycoplasma
part
routin
use
cytotox
assay
rna
synthesi
rsv
polymeras
reconstitut
vitro
use
purifi
rsv
lp
complex
rna
oligonucleotid
templat
dharmacon
repres
nucleotid
rsv
leader
promot
rna
synthesi
reaction
perform
describ
previous
except
reaction
mixtur
contain
rgtp
rutp
rctp
supplement
ctp
either
includ
ratp
atp
condit
polymeras
abl
initi
synthesi
posit
site
promot
posit
site
ntp
metabolit
serial
dilut
dmso
includ
reaction
mixtur
concentr
specifi
fig
rna
product
analyz
electrophoresi
polyacrylamid
gel
contain
urea
tristaurineedta
buffer
radiolabel
rna
product
detect
autoradiographi
transcript
reaction
contain
crude
rsv
rnp
complex
reaction
buffer
mm
trisacet
ph
mm
potassium
acet
glycerol
mm
mm
dtt
mm
egta
bsa
u
rnasin
atp
gtp
utp
ctp
atp
cimmol
radiolabel
nucleotid
use
transcript
assay
select
match
nucleotid
analog
evalu
inhibit
rsv
rnp
transcript
determin
whether
nucleotid
analog
inhibit
rsv
rnp
transcript
compound
ad
use
serial
dilut
increment
incub
rnp
reaction
stop
qiagen
rlt
lysi
buffer
rna
purifi
use
qiagen
rneasi
kit
purifi
rna
denatur
rna
sampl
load
buffer
minut
run
agarosemop
gel
contain
formaldehyd
agaros
gel
dri
expos
storm
phosphorimag
screen
develop
use
storm
phosphorimag
reaction
mixtur
transcript
buffer
mm
hepe
ph
mm
kcl
mm
edta
mm
dtt
glycerol
mm
ng
cmv
control
dna
natur
mixtur
ntp
preincub
variou
concentr
inhibitor
minut
natur
mixtur
ntp
contain
equal
km
compet
ntp
three
ntp
reaction
start
addit
helaextract
h
incub
polymeras
reaction
stop
addit
proteinas
k
mixtur
contain
final
concentr
proteinas
k
sd
mm
edta
incub
h
reaction
mixtur
mix
load
dye
formamid
xylen
cyanol
bromophenol
blue
heat
minut
load
onto
polyacrylamid
gel
urea
gel
dri
minut
expos
phosphorimag
screen
full
length
product
nucleotid
runoff
rna
quantifi
use
typhoon
trio
imag
imag
quant
tl
softwar
twenti
nanomolar
polrmt
incub
nm
templat
plasmid
contain
polrmt
lightstrand
promot
region
transcript
factor
mttfa
nm
nm
buffer
contain
mm
hepe
ph
mm
nacl
mm
dtt
mgml
bsa
mm
reaction
mixtur
preincub
reaction
initi
addit
natur
ntp
incub
minut
reaction
spot
paper
quantifi
homolog
model
ebov
polymeras
built
use
hivrt
xray
crystal
structur
releas
prime
version
llc
new
york
ny
default
set
subsequ
rigid
bodi
minim
side
chain
optim
loop
insert
greater
amino
acid
built
quantit
assess
viral
rna
nonhuman
primat
plasma
sampl
whole
blood
collect
use
edta
greiner
vacuett
tube
equival
sampl
centrifug
rcf
min
inactiv
viru
plasma
treat
part
trireag
ls
sampl
transfer
frozen
storag
remov
rna
extract
carrier
rna
quantifast
high
concentr
intern
control
qiagen
spike
sampl
prior
extract
conduct
accord
manufactur
instruct
viral
rna
elut
ave
buffer
extract
rna
sampl
test
quantifast
intern
control
rtpcr
rna
assay
qiagen
evalu
yield
spikedin
quantifast
high
concentr
intern
control
intern
control
amplifi
within
manufacturerdesign
rang
quantit
analysi
viral
target
perform
rtpcr
conduct
use
abi
fast
dx
use
primer
specif
ebov
glycoprotein
sampl
run
triplic
use
templat
volum
quantit
assess
averag
triplic
genom
equival
ge
per
reaction
determin
multipli
obtain
geml
plasma
standard
curv
gener
use
synthet
rna
limit
quantif
assay
geml
plasma
accept
criteria
posit
templat
control
ptc
neg
templat
control
ntc
neg
extract
control
nec
posit
extract
control
pec
sopspecifi
qualit
assess
limit
detect
lod
defin
ct
base
method
valid
test
anim
consid
test
posit
detect
ebov
rna
minimum
replic
design
posit
ptc
ntc
nec
control
meet
specifi
methodaccept
criteria
sampl
design
posit
ct
valu
lod
ct
three
uninfect
male
rhesu
monkey
macaca
maniculata
use
pharmacokinet
studi
formul
solut
mgml
water
ph
mlkg
administ
slow
bolu
approxim
min
final
dose
mgkg
blood
sampl
plasma
pbmc
collect
femor
veinarteri
taken
monkey
period
plasma
sampl
obtain
predos
h
postdos
pbmc
sampl
obtain
h
blood
sampl
plasma
collect
chill
collect
tube
contain
sodium
fluoridepotassium
oxal
nafkox
anticoagul
immedi
place
wet
ice
follow
centrifug
obtain
plasma
blood
sampl
pbmc
isol
collect
room
temperatur
cpt
vacutain
tube
contain
sodium
heparin
isol
plasma
isol
pbmc
sampl
frozen
immedi
store
analyz
plasma
analysi
aliquot
plasma
sampl
treat
methanol
acetonitril
mixtur
v
v
water
nm
indol
intern
standard
one
hundr
microlit
sampl
filter
agil
captiva
well
filter
plate
filter
sampl
dri
complet
approxim
minut
reconstitut
acetonitril
water
formic
acid
aliquot
inject
lcmsm
use
htc
pal
autosampl
analyt
separ
phenomenex
synergi
hydrorp
column
mm
use
water
acquiti
ultra
perform
lc
water
corpor
milford
usa
flow
rate
mlmin
gradient
mobil
phase
contain
formic
acid
water
acetonitril
mobil
phase
b
contain
formic
acid
acetonitril
water
minut
msm
analysi
use
water
xevo
tq
posit
multipl
reaction
monitor
mode
use
electrospray
probe
plasma
concentr
alamet
nuc
determin
use
calibr
curv
span
concentr
rang
order
magnitud
qualiti
control
sampl
run
begin
end
run
ensur
accuraci
precis
within
intracellular
metabolit
pbmc
quantifi
lcmsm
describ
vitro
activ
studi
six
cynomolgu
monkey
administ
singl
dose
mgkg
iv
administr
slow
bolu
tissu
collect
anim
h
post
dose
tissu
excis
rins
salin
blot
dri
weigh
place
wet
ice
tissu
test
epididymi
eye
brain
follow
homogen
plasma
analyz
liquid
scintil
count
concentr
convert
ng
equival
per
gram
sampl
rhesu
monkey
macaca
mulatta
challeng
day
intramuscular
inject
target
dose
pfu
ebovkikwit
ebola
viru
deriv
clinic
specimen
obtain
outbreak
occur
democrat
republ
congo
formerli
zair
challeng
viru
propag
clinic
specimen
use
cultur
cell
vero
vero
total
four
passag
anim
year
randomli
assign
experiment
treatment
group
stratifi
sex
equal
number
male
femal
per
group
balanc
bodi
weight
use
statist
softwar
cari
north
carolina
usa
studi
personnel
respons
assess
anim
health
includ
euthanasia
assess
administ
treatment
experiment
blind
group
assign
anim
primari
endpoint
efficaci
studi
surviv
day
follow
viru
challeng
formul
gilead
scienc
water
ph
adjust
use
hcl
formul
administ
anesthet
anim
bolu
intraven
inject
rate
approxim
mindos
right
left
saphen
vein
volum
vehicl
inject
mlkg
bodi
weight
anim
anesthet
use
im
inject
solut
contain
ketamin
mgml
acepromazin
mgml
mlkg
bodi
weight
anim
observ
least
twice
daili
monitor
diseas
sign
anim
surviv
day
deem
protect
studi
personnel
allevi
unnecessari
suffer
infect
anim
euthan
clinic
moribund
anim
criteria
use
basi
euthanasia
moribund
anim
defin
prior
studi
initi
includ
magnitud
respons
reduc
bodi
temperatur
andor
specifi
alter
serum
chemistri
serum
chemistri
analyz
use
vitro
chemistri
system
ortho
clinic
diagnost
coagul
paramet
evalu
use
sysmex
coagul
analyz
siemen
healthcar
diagnost
hematolog
analysi
conduct
use
siemen
advia
hematolog
system
multispeci
softwar
siemen
healthcar
diagnost
day
vehicl
dose
schedul
blood
sampl
collect
clinic
patholog
viremia
analysi
blood
sampl
collect
immedi
prior
dose
administr
analysi
viral
genom
sequenc
conduct
purpos
evalu
genom
sequenc
chang
pattern
consist
develop
resist
attempt
made
obtain
sequenc
rnadepend
rna
polymeras
gene
l
ebola
viru
ebovrna
posit
rhesu
monkey
plasma
sampl
obtain
efficaci
studi
deep
sequenc
screen
l
gene
complet
use
previous
describ
mutat
larg
sub
clonal
event
popul
review
nonsynonym
substitut
treat
anim
succumb
infect
substitut
enrich
treat
popul
regardless
surviv
statu
cluster
substitut
treat
anim
cdna
synthesi
perform
use
invitrogen
superscript
iii
firststrand
synthesi
system
cdna
amplifi
phusion
hot
start
flex
dna
polymeras
new
england
biolab
use
overlap
amplicon
primer
inform
avail
upon
request
pool
purif
ampur
xp
reagent
beckman
coulter
pcr
product
fragment
use
covari
instrument
covari
librari
prepar
illumina
truseq
dna
sampl
prepar
kit
illumina
calip
liquid
handl
station
perkinelm
measur
realtim
pcr
kapa
qpcr
kit
kapa
biosystem
librari
dilut
nm
cluster
amplif
perform
illumina
cbot
librari
sequenc
illumina
nextseq
illumina
hiseq
use
bp
pairedend
format
viral
assembl
complet
dnastar
lasergen
ngen
amplif
primer
remov
qualiti
trim
trimtom
perform
read
minimum
similar
refer
fourbas
mismatch
target
depth
sought
snp
posit
fewer
read
depth
remov
analysi
consensu
chang
defin
chang
rel
deposit
ebov
sequenc
genbank
present
popul
threshold
snp
consid
subclon
substitut
part
minor
subpopul
viru
consensu
sequenc
region
cover
screen
avail
genbank
access
number
provid
extend
data
tabl
pharmacokinet
radiolabel
tissu
distribut
studi
uninfect
cynomolgu
rhesu
macaqu
conduct
covanc
inc
madison
wi
protocol
review
institut
anim
care
use
committe
iacuc
covanc
efficaci
experi
involv
ebov
perform
usamriid
research
conduct
institut
anim
care
use
committe
approv
protocol
complianc
anim
welfar
act
ph
polici
feder
statut
regul
relat
anim
experi
involv
anim
facil
research
conduct
accredit
associ
assess
accredit
laboratori
anim
care
intern
strictli
adher
principl
state
guid
care
use
laboratori
anim
nation
research
council
nation
academi
press
washington
dc
combin
vehicl
group
part
n
anim
total
use
control
group
statist
comparison
impact
treatment
surviv
rate
estim
use
kaplanmei
method
analyz
logrank
analysi
use
dunnetthsu
procedur
adjust
multipl
comparison
effect
system
viral
rna
level
assess
analysi
varianc
anova
compar
treatment
group
vehicl
group
use
dunnett
test
adjust
multipl
comparison
wilcoxon
ranksum
test
without
adjust
multipl
comparison
use
compar
effect
treatment
hematolog
coagul
clinic
chemistri
paramet
data
met
statist
assumpt
test
perform
